Distributor inventory
Insulin glulisine 100 IU/mL (3 mL prefilled pen)
Treatment of diabetes mellitus (Type 1 and Type 2) to improve glycaemic control; used as prandial (mealtime) insulin as part of a basal-bolus regimen.
Insulin glulisine is a rapid-acting insulin analogue that lowers blood glucose by increasing glucose uptake in muscle and fat and reducing hepatic glucose production. It also inhibits lipolysis and proteolysis and promotes protein synthesis.
Subcutaneous injection using the prefilled pen. Inject within 15 minutes before a meal or within 20 minutes after starting a meal, as prescribed. Rotate injection sites (abdomen, thigh, upper arm); do not inject into veins or muscles unless specifically instructed. Do not share the pen; use a new needle for each injection.
Common side effects of APIDRA SOLOSTAR may include:
Risk of severe hypoglycaemia—monitor blood glucose regularly and carry fast-acting sugar. Dose adjustments may be needed with changes in diet/exercise, illness, stress, or switching insulin. Use caution in renal or hepatic impairment (may need lower dose). Do not use if solution is cloudy/colored or pen is damaged; do not freeze. Allergy to insulin glulisine/excipients is a contraindication. Use caution while driving/operating machinery due to hypoglycaemia risk.
